Rabbit corneal allograft survival following topical administration of cyclosporin A.
Cyclosporin A (CS-A), selectively inhibited cellular immunity, delayed the skin graft-induced rejection of corneal allografts in rabbits when administered subconjunctivally in the dose of 3 mg/kg/day or in the form of 5% water-soluble drops five times daily for 28 days. The subconjunctival application of CS-A was irritating, whereas the topical instillation of the water-soluble preparation was well tolerated. The corneal grafts were rejected after discontinuation of the therapy. Rejection was confirmed by scanning and transmission electron microscopy. The mechanism by which CS-A delayed corneal graft rejection seems to depend mainly on the specific and/or the nonspecific effect of topical CS-A on lymphocytes.
D000287:Administration, Topical; D000818:Animals; D003524:Cyclosporins / Q000008:administration & dosage / Q000494:pharmacology*; D006084:Graft Rejection / Q000187:drug effects; D006085:Graft Survival / Q000187:drug effects*; D008954:Models, Biological; D009883:Ophthalmic Solutions; D011817:Rabbits; D012160:Retina / Q000473:pathology / Q000637:transplantation*; D014184:Transplantation, Homologous
D003524:Cyclosporins; D009883:Ophthalmic Solutions